Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.

MLA

Théophile, Hélène, et al. “Validation and Reproducibility of the Updated French Causality Assessment Method: An Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.” Therapie, vol. 70, no. 5, Sept. 2015, pp. 465–76. EBSCOhost, https://doi.org/10.2515/therapie/2015028.

APA

Théophile, H., Dutertre, J.-P., Gérardin, M., Valnet-Rabier, M.-B., Bidault, I., Guy, C., Haramburu, F., Hillaire-Buys, D., Méglio, C., & Arimone, Y. (2015). Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies. Therapie, 70(5), 465–476. https://doi.org/10.2515/therapie/2015028

Chicago

Théophile, Hélène, Jean-Paul Dutertre, Marie Gérardin, Marie-Blanche Valnet-Rabier, Irène Bidault, Claire Guy, Françoise Haramburu, Dominique Hillaire-Buys, Carmine Méglio, and Yannick Arimone. 2015. “Validation and Reproducibility of the Updated French Causality Assessment Method: An Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.” Therapie 70 (5): 465–76. doi:10.2515/therapie/2015028.